top headlines
Polaryx Therapeutics is preparing to start its Phase 2 SOTERIA [...]
Lumen Bioscience has received up to $7m in US government [...]
Movers & Shakers
sponsored content
Saama’s Chief Customer Success and Growth Officer Ari Srinivasan speaks [...]
In this exclusive interview with Liza Laws for Discover Pharma, [...]
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
Other news
Genespire has started enrolling children with severe methylmalonic acidemia in [...]
Insilico Medicine has launched an open consortium and benchmark index [...]
The FDA has granted Fast Track designation to Erasca’s investigational [...]
Anthropic’s Claude AI models generated protein binders against 15 targets, [...]
The FDA has granted De Novo marketing authorisation to Avulux, [...]
University of Oxford-led research will examine whether artificial intelligence can [...]
